News|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds
This article provides guidance for developing dissolution testing for poorly soluble compounds. It is the second of a series of articles based on material from a 2003 PhRMA workshop about acceptable analytical practices.
Advertisement
Articles in this issue
about 21 years ago
In the Spotlight-December 2004about 21 years ago
Safety Problems Roil Pharma and FDAabout 21 years ago
December 2004about 21 years ago
Robust CRO Market Is Driving New Merger and Acquisition Activityabout 21 years ago
The Seventh Annual International Employment Surveyabout 21 years ago
Pharmaco-FakeryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
De-risking Biologic Development: Engineering Flexibility from Early Development to Launch
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
4
Behind the Headlines Episode 30: 2026 Wish List
5